HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Revlon Targets Prestige Channel, Fragrance Growth With Elizabeth Arden Buy

This article was originally published in The Rose Sheet

Executive Summary

Firm’s $870m acquisition of Elizabeth Arden is seen as “highly complementary,” bringing prestige skin care and scalable fragrance licenses to its existing business focused on mass and salon beauty and hair care. The deal also offers synergies and cost-reduction opportunities for both companies, which have struggled in recent years to rejuvenate their businesses.

You may also be interested in...



Revlon Doubles China Biz, Grows E-Commerce 66%; But Alas, North America

On the bright side in North America, the Revlon brand has reclaimed its lead in the US mass lip segment, and both Revlon and Almay are off to strong starts in the fourth quarter, company leadership says. The firm continues to build the international and digital sides of its business in search of sustainable growth outside of Elizabeth Arden.

Revlon Highlights Flesh Beauty Launch, China Momentum In Q2 Report

The firm remains in brand- and digital-building mode, but it’s seeing marked progress while looking forward to planned H2 innovations and the impact of its recently introduced Flesh line of “inclusive” color cosmetics. Opportunity beckons in China, where Revlon’s second-quarter sales grew 46%.

Revlon CEO Garcia Resigns Amid Continued Turnaround Challenges

The former Colgate-Palmolive exec served less than two years as CEO of Revlon, which continues to be plagued by declining sales and widening losses despite brand revival efforts and investments in e-commerce. There were bright spots in the fourth quarter, including renewed growth in the firm's US color cosmetics business.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019961

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel